About Nordic Bioscience
Nordic Bioscience is a Healthcare company based in Herlev (Denmark) founded in 1996. Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform. Its chief executive, as recorded, is Morten Asser Karsdal. Nordic Bioscience offers products and services including Biomarker Solutions, Laboratory Services, and Biomarker Portfolio. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is Nordic Bioscience A/S.
Company details
Nordic Bioscience was established in 1996 in Herlev, Denmark, as a contract research organization focused on the biopharmaceutical sector. Preclinical and clinical drug development services are offered, supported by a proprietary in-house biomarker platform. Operations emphasize biomarker-based assays for disease progression and treatment efficacy. The company serves clients in drug discovery and validation across various therapeutic areas, with headquarters in Denmark facilitating European and global collaborations.
- Headquarters Herlev, Denmark
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website nordicbioscience.com
- Social LinkedIn X YouTube
- Legal Name Nordic Bioscience A/S
- InvestorsKKR
& 1 more
Products & Services of Nordic Bioscience
Nordic Bioscience offers a comprehensive portfolio of products and services, including Biomarker Solutions, Laboratory Services, and Biomarker Portfolio.
Tools for chronic disease analysis and precision medicine
Analysis for preclinical and clinical samples in drug development
Collection of biomarkers for various disease areas
Apps and channels of Nordic Bioscience
its YouTube channel Nordic Bioscience has 2.31K subscribers and 30 videos.
Videos from Nordic Bioscience
The most watched videos on Nordic Bioscience's YouTube channel, Nordic Bioscience (2.31K subscribers). Click a video to play it here.
More on Nordic Bioscience.
Funding Insights of Nordic Bioscience
- Total Rounds 7
- First Round $701,337
(Jan 2015)
- Investors Count 2
All 7 funding rounds of Nordic Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | Private Equity Round | – | KKR | – | |
| Apr 2020 | $72,335 | Grant | – | – | |
| Jan 2019 | $681,968 | Grant | – | – | |
| Jan 2017 | $305,337 | Grant | – | – | |
| Jan 2016 | $327,300 | Grant | – | – | |
| May 2015 | $210,000 | Grant | – | – | |
| Jan 2015 | $701,337 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Nordic Bioscience
Nordic Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Nordic Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nordic Bioscience
7 people are tracked at Nordic Bioscience (3 in leadership, 3 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Morten Asser Karsdal | CEO | Leadership |
Thomas Nielsen | CFO | Leadership |
Morten Karsdal | CEO | Leadership |
Bente Christiansen | Chairperson | Board & advisors |
Claus Christiansen | Board Member | Board & advisors |
Henrik Bernt Sanders | Board Member | Board & advisors |
Amanda Leu | Financial Controller | Team |
Complete people profiles for Nordic Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nordic Bioscience
3 dated milestones of Nordic Bioscience across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Nordic Bioscience is founded.
- Funding First funding round of $701K.
- Funding Latest funding round, Private Equity Round,.
Web traffic of Nordic Bioscience
The website of Nordic Bioscience (nordicbioscience.com) receives about 8.5K visits a month and ranks #2,319,491 among all websites worldwide, #3,171 in Biotechnology and Pharmaceuticals.
- Monthly visits8.5K
▼ 10.8% vs previous month
- Unique visitors4K
per month
- Global rank#2,319,491
among all websites
- Category rank#3,171
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.8
- Average visit33 sec
- DevicesDesktop 36% · Mobile 64%
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nordic Bioscience
Complete news archive for Nordic Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nordic Bioscience
Nordic Bioscience was founded in 1996 and raised its 1st funding round 19 years after it was founded.
Nordic Bioscience is headquartered in Herlev, Denmark.
Morten Asser Karsdal is the CEO of Nordic Bioscience, as recorded in our data.
Nordic Bioscience was established in 1996 in Herlev, Denmark, as a contract research organization focused on the biopharmaceutical sector. Preclinical and clinical drug development services are offered, supported by a proprietary in-house biomarker platform. Operations emphasize biomarker-based assays for disease progression and treatment efficacy. The company serves clients in drug discovery and validation across various therapeutic areas, with headquarters in Denmark facilitating European and global collaborations.
Nordic Bioscience offers Biomarker Solutions, Laboratory Services, and Biomarker Portfolio.
Nordic Bioscience has 2 investors. Key investors include KKR, and European Union.
Nordic Bioscience operates through Nordic Bioscience A/S.